An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Increasing antidiabetic drugs use in youths has been reported in the USA, however there is a lack of epidemiological evidence in the UK. • There is an increase in the prevalence of both type 1 and 2 diabetes, but precise estimates are difficult to obtain and as such are uninformative for future health services planning. WHAT THIS STUDY ADDS • The prevalence of children receiving insulin and oral antidiabetic drugs has increased twofold and eightfold, respectively, between 1998 and 2005. • The data reflect the prevalence of both type 1 and type 2 diabetes rapidly increase in recent years. • The prevalence of antidiabetic drug use increases with increasing age, especially among those aged 12–18 years. • Consideration needs to be given to the funding and design of future services for children and particularly adolescents with diabetes to take account of these epidemiological findings. AIMS Despite evidence of an increase in the incidence of both type 1 and type 2 diabetes in youths, there are few data on the prevalence of either type in children and adolescents. The aim of this study was to investigate the prevalence of childhood diabetes over an 8‐year period in the UK. METHODS This was a retrospective cohort study that covered 8 years (January 1998 to December 2005) of UK IMS Disease Analyzer (IMS DA) data. The cohort comprised all children and adolescents aged 0–18 years who received at least one antidiabetic drug prescription during the study period. The prevalence of antidiabetic drug prescribing was used as a proxy for diabetes itself. RESULTS Data were available on 505 754 children aged 0–18 years and a total of 37 225 antidiabetic prescriptions were issued. Insulin use increased significantly from 1.08 per 1000 children [95% confidence interval (CI) 0.96, 1.20] in 1998 to 1.98 (95% CI 1.80, 2.10) in 2005 (P < 0.001), more markedly in those aged 12 and 18 years. The use of oral antidiabetic drugs for diabetes treatment rose significantly from 0.006 per 1000 children in 1998 (95% CI 0.0043, 0.017) to 0.05 (95% CI 0.025, 0.080) (P < 0.001) in 2005. CONCLUSIONS This study indicates a significant increase in prevalence on both type 1 and type 2 diabetes treatment in children and adolescents in the UK. Thus, this supporting evidence from other sources that the prevalence of childhood diabetes is rising rapidly. Further epidemiological studies are required to investigate the aetiology and risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group
Karvonen, M., Viik-Kajander, M., Moltchanova, E., Libman, I., LaPorte, R., & Tuomilehto, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1516 · Cited by 1,072
Incidence of diabetes in youth in the United States
SEARCH for Diabetes in Youth Study Group*, T. W. G. F. T. (2007) · JAMA · doi:10.1001/jama.297.24.2716 · Cited by 991
Rising Incidence of Type 2 Diabetes in Children in the U.K.
Haines, L., Wan, K. C., Lynn, R., Barrett, T. G., & Shield, J. P. H. (2007) · Diabetes Care · doi:10.2337/dc06-1813 · Cited by 258
Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth
Vehik, K., Hamman, R. F., Lezotte, D., Norris, J. M., Klingensmith, G., Bloch, C., Rewers, M., & Dabelea, D. (2007) · Diabetes Care · doi:10.2337/dc06-1837 · Cited by 226
Cited by
Young-onset type 2 diabetes mellitus — implications for morbidity and mortality
Magliano, D. J., Sacre, J. W., Harding, J. L., Gregg, E. W., Zimmet, P. Z., & Shaw, J. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0334-z · Cited by 483
Early onset type 2 diabetes: risk factors, clinical impact and management
Wilmot, E., & Idris, I. (2014) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314548679 · Cited by 269
Association of Short and Long Sleep Durations with Insulin Sensitivity in Adolescents
Javaheri, S., Storfer-Isser, A., Rosen, C. L., & Redline, S. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.09.080 · Cited by 139
Child, C. J., Zimmermann, A. G., Scott, R. S., Cutler, G. B., Battelino, T., & Blum, W. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-3023 · Cited by 71
Caamano-Isorna, F., Figueiras, A., Sastre, I., Montes-Martínez, A., Taracido, & Piñeiro-Lamas, M. (2011) · Environmental Health · doi:10.1186/1476-069x-10-48 · Cited by 71
“Our study has the following three main limitations: (1) it has been argued that the validity of these types of studies can be questioned [10,44], due to underdiagnosis [10], drug non-specificity for a single pathology [9,10,44], existence of patients diagnosed for non-pharmacological treatments [10], physician-prescri…”
Background
Metadata
- Authors
- Hsia, Y., Neubert, A. C., Rani, F., Viner, R. M., Hindmarsh, P. C., & Wong, I. C. K.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2009-02
- Volume
- 67
- Issue
- 2
- Pages
- 242-249
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2089142428
- Cited by
- 86
- References
- 4
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. https://app.cochat.ai/papers/10.1111/j.1365-2125.2008.03347.x
- The paper
- Hsia, Y., Neubert, A. C., Rani, F., Viner, R. M., Hindmarsh, P. C., & Wong, I. C. K. (2009). An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2008.03347.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.